Amvis Holds to Forecast as Profits Slide Despite Higher Sales

Amvis Holdings.Inc. ( (JP:7071) ) has issued an update.

Amvis Holdings reported consolidated net sales of ¥25.6 billion for the six months ended March 31, 2026, up 7.5% year on year, but profitability deteriorated, with EBITDA down 11.5% and profit attributable to owners of parent falling 29.5% to ¥1.9 billion as margins came under pressure. Despite the earnings decline, total assets remained broadly flat at about ¥84 billion and the shareholders’ equity ratio improved to 45.2%, while the company maintained its full-year forecast for modest sales growth to ¥51.7 billion but sharp declines in profit, and kept its annual dividend outlook at ¥4 per share, signaling a cautious but steady shareholder return policy.

For the fiscal year ending September 30, 2026, Amvis forecasts a 5.1% rise in net sales but expects EBITDA to drop 20.8% and profit attributable to owners of parent to fall 42.6% to ¥2.1 billion, pointing to ongoing cost and margin challenges. The unchanged guidance suggests management sees no immediate catalyst for earnings recovery, which may weigh on investor sentiment even as a stronger equity base and stable dividend plan offer some support to longer-term stakeholders.

More about Amvis Holdings.Inc.

Amvis Holdings, Inc. is listed on the Tokyo Stock Exchange and operates in the healthcare and medical services sector, focusing on facilities and services for patients requiring long-term or specialized care. The company generates revenue primarily through its network of care facilities and related medical support operations in Japan, targeting stable, recurring income in an aging society.

Average Trading Volume: 600,487

Technical Sentiment Signal: Sell

Current Market Cap: Yen37.46B

Learn more about 7071 stock on TipRanks’ Stock Analysis page.